Pentagon rescinds new testosterone screening policy without explanation
Following Defense Secretary Pete Hegseth's startling announcement in July that the US military would begin mandatory testosterone screening for personnel, the Pentagon released a clinical guidance document on September 2 outlining the new medically questionable policy. The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell. The withdrawal was first reported by Reuters . In a statement sent to Ars Technica, the Pentagon said that the document, titled "Clinical Guidance for Health and Human Performance Optimization," had been temporarily rescinded on September 3 to allow for updates. Read full article Comments
Following Defense Secretary Pete Hegseth's startling announcement in July that the US military would begin mandatory testosterone screening for personnel, the Pentagon released a clinical guidance document on September 2 outlining the new medically questionable policy.
The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell. The withdrawal was first reported by Reuters .
The Pentagon says the guidance is being updated after being online for one day.
“The Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members, and enabling peak operational performance,” the Pentagon said. An interim guidance remains in effect, and “the final clinical guidance will be issued shortly,” it added.
The Pentagon declined to provide more information regarding what was being updated about the guidance and why it needed to be updated so quickly after its release.
